Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safe Return to Regular Clinical Operation After COVID-19 Pandemic; (Oncology Center, Prospective Cohort)

NCT04377802 is registered in ClinicalTrials.gov with King Fahad Specialist Hospital Dammam as lead sponsor.

NCT NCT04377802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04377802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safe Return to Regular Clinical Operation After COVID-19 Pandemic; (Oncology Center, Prospective Cohort)
Lead sponsor
King Fahad Specialist Hospital Dammam
Phase
Not applicable
Overall status
Unknown status
Start date
May 17, 2020
Completion date
December 30, 2020
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19